Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 1, 2016, Pages 392-400

  Pradhan, Madhulika ^a   Singh, Deependra ^a   Singh, Manju Rawat ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Corticosteroid; Dermal disorders; Process variables; Psoriasis; Solid lipid nanoparticles; Triamcinolone acetonide

Indexed keywords

DRUG PRODUCTS; NANOPARTICLES; PARTICLE SIZE;

CORTICOSTEROID; DERMAL DISORDERS; PROCESS VARIABLES; PSORIASIS; SOLID LIPID NANOPARTICLE (SLN); TRIAMCINOLONE ACETONIDE;

ACETONE;

SOLID LIPID NANOPARTICLE; TRIAMCINOLONE ACETONIDE; ACRYLIC ACID DERIVATIVE; ANTIINFLAMMATORY AGENT; CARBOMER; DELAYED RELEASE FORMULATION; DIACYLGLYCEROL; FATTY ACID; GEL; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; NANOPARTICLE; STEARIC ACID; STEARIC ACID DERIVATIVE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; POWDER X RAY DIFFRACTION; SKIN DISEASE; TOPICAL TREATMENT; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL; ANIMAL; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DELAYED RELEASE FORMULATION; DIFFUSION CHAMBER; DRUG EFFECTS; DRUG STABILITY; GEL; GOAT; METABOLISM; PERMEABILITY; PHARMACOKINETICS; PHARMACOLOGY; SKIN; SKIN ABSORPTION; ULTRASTRUCTURE;

ACRYLATES; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DELAYED-ACTION PREPARATIONS; DIFFUSION CHAMBERS, CULTURE; DIGLYCERIDES; DRUG COMPOUNDING; DRUG LIBERATION; DRUG STABILITY; FATTY ACIDS; GELS; GOATS; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; SKIN; SKIN ABSORPTION; STEARIC ACIDS; TRIAMCINOLONE ACETONIDE;

EID: 84964374907     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.955105     Document Type: Article

References (33)

1. Charoenputtakhun P, Opanasopit P, Rojanarata T, Ngawhirunpat T. 2014. All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier. Pharm Dev Technol. 19: 164-172.
2. Chen H, Chang X, Du D, Liu W, Liu J, Weng T, et al. 2006. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release. 110: 296-306.
3. Das S, Ng WK, Kanaujia P, Kim S, Tan RBH 2011. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces. 88: 483-489.
4. Das S, Ng WK, Tan RB. 2012. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47: 139-151.
5. Ghadiri M, Fatemi S, Vatanara A, Doroud D, Najafabadi AR, Darabi M, Rahimi AA. 2012. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm. 424: 128-37.
6. Gupta M, Tiwari S, Vyas SP. 2013. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fuconazole against cutaneous candidiasis. Pharm Dev Technol. 18: 550-559.
7. Gupta V, Trivedi P. 2014. Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies. Artif Cells Nanomed Biotechnol. Early Online: 1-10, doi: 10.3109/21691401.2014.893523.
8. Hao J, Wang F, Wang X, Zhang D, Bi Y, Gao Y, et al. 2012. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Pharm Sci. 47: 497-505.
9. Agrawal Y, Petkar KC, Sawant KK. 2010. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 401: 93-102.
10. Khurana S, Bedi PMS, Jain NK. 2013a. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem Phy Lipids. 175: 65-72.
11. Khurana S, Jain NK, Bedi PMS 2013b. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam Life Sci. 93: 763-772.
12. Lason E, Sikora E, Ogonowski J. 2013. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation. Acta Biochemica Polonica. 60: 773-777.
13. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. 2007. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 328: 191-195.
14. Liu M, Dong J, Yang Y, Yang X, Xu H. 2005. Characterization and release of triptolide-loaded poly (d, l-lactic acid) nanoparticles. Eur Polym J. 41: 375-382.
15. Liu W, Hu M, Liu W, Xu CB, Xu H, Yang XL. 2008. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm. 364: 135-141.
16. Lopes LB, Ferreira DA, Paula D, Garcia MJ, Thomazini JA, Fantini MA, Bentley MB. 2006. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of Cyclosporin A. Pharm Res. 23: 1332-1342.
17. Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH. 2011. Lipid nano-carriers for dermal delivery of lutein: Preparation, characterization, stability and performance. Int J Pharm. 414: 267-275.
18. Mulla JS, Khazi IM. 2009. Influence of process variables on particle size of solid lipid nanoparticles. Ind J Novel Drug Deliv. 1: 47-49.
19. Patil GB, Patil ND, Deshmukh PK, Patil PO, Bari SB. 2014. Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: application of factorial design approach. Artif Cells Nanomed Biotechnol. Early online, doi: 10.3109/21691401.2014.909820.
20. Pouton CW 2006. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 29: 278-287.
21. Pradhan M, Singh D, Singh MR. 2013. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 170: 380-395.
22. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. 2011. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 63: 470-491.
23. Rawat M, Saraf S, Saraf S. 2007. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS Pharm Sci Tech. 4: 289-297.
24. Samein LH 2014. Preparation and evaluation of nystatin loaded-solid-lipid nanoparticles for topical delivery. Int J Pharm Pharm Sci. 6: 592-597.
25. Schafer-Korting M, Mehnert W, Korting HC. 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 59: 427-443.
26. Singh D, Dubey P, Pradhan M, Singh MR. 2013. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery. Expert Opin Drug Deliv. 10: 241-259.
27. Singh D, Nag M, Pradhan M, Singh MR. 2014. Vesicular system: versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol. Early Online, doi: 10.3109/21691401.2014.883401.
28. Singh M, Singh D, Saraf S. 2011. Influence of selected formulation variables on the preparation of peptide loaded lipospheres. Trends Med Res 6: 863-876.
29. Singh MR, Pradhan K, Singh D. 2012. Lipid Matrix Systems with emphasis on lipid microspheres: Potent Carriers for Transcutaneous Delivery of Bioactives. Curr Drug Deliv. 9: 243-254.
30. Subedi RK, Kang KW, Choi H. 2009. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 37: 508-513.
31. Trotta M, Gallarate M, Pattarino F, Morel S. 2001. Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. J Control Release. 76: 119-128.
32. Uner M, Karaman E F, Aydoǧmuş Z. 2014. Solid lipid nanoparticles and nanostructured lipid carriers of loratadine for topical application: physicochemical stability and drug penetration through rat skin. Tropical J Pharm Res. 13: 653-660.
33. Vitorino C, Carvalho FA, Almeida AJ, Sousa JJ, Pais AA. 2011. The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids Surf B Biointerfaces. 84: 117-130.